Dear Editor, Freitas C et al 1 recently published a case report on a widely discussed topic in psychiatry, concerning the risk of manic switch with the use of antidepressants. This topic is of the utmost importance especially considering today's widespread use of antidepressants in a wide range of medical conditions. Although the risk of switching with antidepressants is well established, its adverse effects in the management in other clinical conditions are often underestimated in psychiatry. At the core of this issue is the accurate diagnosis of depressive episodes. Today's classification systems on mood disorders are largely based on a polarity dichotomy (unipolar versus bipolar). Frequently it is assumed that any depressive state is synonymous with the diagnosis of unipolar depression, overlooking subsyndromal signs of hypomanic or mixed depressive states. A previous history of treatment resistant depression, irritability, mood lability, mixed features in response to antidepressants is associated with a possible underlying bipolar diathesis. 2 Indeed, some authors propose that up to half of supposedly unipolar depressive episodes presenting in clinical practice might be diagnosed as depressive mixed states if one takes into consideration criteria excluded from DSM 5 mixed features specifier (such as psychomotor agitation, distractibility, irritability, racing thoughts). 3, 4 Radical thinkers go as far as proposing the apparently controversial view that depression is a consequence of manic states. 3 According to this point of view, antidepressants are ineffective and harmful in the treatment of most depressive episodes presenting in clinical practice, and thus contribute to induce further mood instability in these patients. Indeed, most depressive states in clinical practice would involve mixed depressive states, affective temperaments (cyclothymia and hyperthymia) and classical bipolar depression. 5 Misdiagnosis of soft bipolar spectrum disorders or temperamental dysregulations (such as cyclothymia) may lead to frustration amongst clinicians with patients failing to improve and apparently resisting to recommended pharmacological and psychological treatment. The mainstay treatment should include the slow discontinuation of antidepressants and the use of drugs with mood stabilizing properties (lithium, anticonvulsants and second-generation antipsychotics). 4, 5 Current evidence would recommend against the use of antidepressant monotherapy in the treatment of bipolar spectrum depression.
The key message is to be mindful of associated features and signs that depressive episodes (even in the absence of past mania or hypomania) might not be truly 'unipolar' (Table 1). This might help to prevent misdiagnosis and inappropriate treatment strategies with potential negative long-term prognostic implications (including increased suicide risk).
